[HTML][HTML] Metabolic reprogramming and disease progression in cancer patients

L Torresano, C Nuevo-Tapioles… - … et Biophysica Acta (BBA …, 2020 - Elsevier
Genomics has contributed to the treatment of a fraction of cancer patients. However, there is
a need to profile the proteins that define the phenotype of cancer and its pathogenesis. The …

The multifaceted ATPase inhibitory factor 1 (IF1) in energy metabolism reprogramming and mitochondrial dysfunction: a new player in age-associated disorders?

E Gore, T Duparc, A Genoux, B Perret… - Antioxidants & Redox …, 2022 - liebertpub.com
Significance: The mitochondrial oxidative phosphorylation (OXPHOS) system, comprising
the electron transport chain and ATP synthase, generates membrane potential, drives ATP …

Coordinate β-adrenergic inhibition of mitochondrial activity and angiogenesis arrest tumor growth

C Nuevo-Tapioles, F Santacatterina… - Nature …, 2020 - nature.com
Mitochondrial metabolism has emerged as a promising target against the mechanisms of
tumor growth. Herein, we have screened an FDA-approved library to identify drugs that …

Anoikis patterns exhibit distinct prognostic and immune landscapes in osteosarcoma

Z Zhang, Z Zhu, J Fu, X Liu, Z Mi, H Tao… - International …, 2023 - Elsevier
Objectives Osteosarcoma is highly aggressive and prone to metastasis, with a poor
prognosis. Increasing evidence identified anoikis has a critical effect in tumor metastasis and …

Generation of mitochondrial reactive oxygen species is controlled by ATPase inhibitory factor 1 and regulates cognition

PB Esparza-Moltó, I Romero-Carramiñana… - PLoS …, 2021 - journals.plos.org
The mitochondrial ATP synthase emerges as key hub of cellular functions controlling the
production of ATP, cellular signaling, and fate. It is regulated by the ATPase inhibitory factor …

[HTML][HTML] A novel Anoikis and immune-related genes marked prognostic signature for colorectal cancer

Z Cai, F Zhou - Medicine, 2022 - journals.lww.com
Colorectal cancer (CRC) is second most commonly diagnosed cancer with high morbidity
and mortality. The heterogeneity of CRC makes clinical treatment tremendously challenging …

Mitochondrial dynamics and cristae shape changes during metabolic reprogramming

I Kawano, B Bazila, P Ježek… - Antioxidants & Redox …, 2023 - liebertpub.com
Significance: The architecture of the mitochondrial network and cristae critically impact cell
differentiation and identity. Cells undergoing metabolic reprogramming to aerobic glycolysis …

The F1Fo-ATPase inhibitor protein IF1 in pathophysiology

C Gatto, M Grandi, G Solaini, A Baracca… - Frontiers in …, 2022 - frontiersin.org
The endogenous inhibitor of ATP synthase is a protein of about 10 kDa, known as IF1 which
binds to the catalytic domain of the enzyme during ATP hydrolysis. The main role of IF1 …

The Mitochondrial ATP Synthase/IF1 Axis in Cancer Progression: Targets for Therapeutic Intervention

S Domínguez-Zorita, JM Cuezva - Cancers, 2023 - mdpi.com
Simple Summary Cancer is a global health problem with high personal and economic
burden worldwide. The reprogramming of metabolism experienced by carcinomas offers a …

The Prognosis of Cancer Depends on the Interplay of Autophagy, Apoptosis, and Anoikis within the Tumor Microenvironment

S Gulia, P Chandra, A Das - Cell Biochemistry and Biophysics, 2023 - Springer
Within the tumor microenvironment, the fight between the immune system and cancer
influences tumor transformation. Metastasis formation is an important stage in the …